Adone Rosanna, Sali Michela, Francia Massimiliano, Iatarola Michela, Donatiello Adelia, Fasanella Antonio
Istituto Superiore di Sanità Rome, Italy.
Università Cattolica del Sacro Cuore Rome, Italy.
Front Microbiol. 2016 Jan 28;7:19. doi: 10.3389/fmicb.2016.00019. eCollection 2016.
Anthrax is a zoonotic disease caused by Bacillus anthracis spore-forming bacterium. Since it is primarily a disease of animals, the control in animals, and humans depend on the prevention in livestock, principally cattle, sheep, and goats. Most veterinary vaccines utilize the toxigenic, uncapsulated (pXO1+/pXO2-) B. anthracis strain 34F2 which affords protection through the production of neutralizing antibodies directed to the toxin components Protective Antigen (PA), Lethal Factor (LF), and Edema Factor (EF). The titration of specific antibodies in sera of vaccinated animals is crucial to evaluate the efficacy of the vaccination and to obtain epidemiological information for an effective anthrax surveillance. In this study, we developed a Sterne-based Complement Fixation Test (CFT) to detect specific antibodies induced in animals vaccinated with Sterne 34F2. We assessed its efficacy in laboratory animals and under field conditions by monitoring the humoral response induced by vaccination in cattle. The results indicated that the Sterne-based CFT is able to correctly identify vaccinated animals. It proved to be a very sensitive and specific test. Moreover, the Sterne-based CFT offers many benefits with regard to costs, standardization and reproducibility of the assay procedure.
炭疽是一种由炭疽芽孢杆菌引起的人畜共患病。由于它主要是一种动物疾病,对动物和人类的控制取决于对家畜(主要是牛、羊和山羊)的预防。大多数兽用疫苗使用产毒的、无荚膜的(pXO1+/pXO2-)炭疽芽孢杆菌34F2菌株,该菌株通过产生针对毒素成分保护性抗原(PA)、致死因子(LF)和水肿因子(EF)的中和抗体来提供保护。对接种疫苗动物血清中的特异性抗体进行滴定对于评估疫苗接种效果和获取有效的炭疽监测流行病学信息至关重要。在本研究中,我们开发了一种基于斯特恩疫苗株的补体结合试验(CFT),以检测用斯特恩34F2疫苗接种的动物体内诱导产生的特异性抗体。我们通过监测牛接种疫苗后诱导的体液反应,在实验动物和野外条件下评估了其效果。结果表明,基于斯特恩疫苗株的CFT能够正确识别接种疫苗的动物。它被证明是一种非常灵敏和特异的检测方法。此外,基于斯特恩疫苗株的CFT在检测成本、标准化和检测程序的可重复性方面具有诸多优势。